Acadia Pharmaceuticals Inc. (ACAD)
Market Closed
17 Jul, 20:00
$
25. 60
-0.03
-0.1171%
$
4.49B Market Cap
- P/E Ratio
- Div Yield
1.21M Volume
-0.34 Eps
$ 25.63
Previous Close 
Want to track ACAD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Acadia Pharmaceuticals Inc. (ACAD) Statistics
Valuation metrics
Market Cap 4.49B
Enterprise value 4.15B
Trailing P/E (ttm) 11.48
Forward P/E 23.63
PEG ratio 0.19
Price/Sales (ttm) 4
Price/Book (mrq) 3.5
Enterprise Value/Revenue 3.79
Enterprise Value/EBITDA 32.72
Overview
Shares outstanding 171.09M
Float 127.25M
Shares short 11.16M
% Held by insiders 0%
% Held by institutions 0.99%
Average volume (10 days) 1.47M
Average volume (90 days) 1.71M
Price summary
52-Week low 19.69
52-Week high 28.35
Beta 0.86
50-Day moving average 24.31
200-Day moving average 23.24
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.34%
Operating margin 0.07%
Operational effectiveness
Return on assets 0.23%
Return on equity 0.36%
Income Statement
Revenue (ttm) 1.1B
Revenue per share (ttm) 6.42
Quarterly revenue growth (yoy) 0.1%
Gross profit (ttm) 674.45M
EBITDA 116.57M
Net income to common (ttm) 375.65M
Diluted EPS (ttm) 2.2
Quarterly earnings growth (yoy) -0.81%
Balance Sheet
Total cash (mrq) 851.46M
Total cash per share (mrq) 4.99
Total debt (mrq) 50.79M
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 3.59%
Book value per share (mrq) 7.32
Cash Flow
Cash flow statement 123.49M
Levered free cash flow (LFCF) 154.14M
